UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 104

Sortiert nach

Pronounced maternal parent-of-origin bias for type-1 NF1 microdeletions

Human genetics, 2018-05, Vol.137 (5), p.365-373

2018

Link zum Volltext

Verfügbarkeit prüfen

The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1

PloS one, 2020-04, Vol.15 (4), p.e0232031-e0232031

2020

Link zum Volltext

Verfügbarkeit prüfen

Management of neurofibromatosis type 1-associated plexiform neurofibromas

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (11), p.1827-1844

2022

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis

PloS one, 2012-04, Vol.7 (4), p.e35711-e35711

2012

Link zum Volltext

Verfügbarkeit prüfen

Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1

Neuro-oncology (Charlottesville, Va.), 2008-08, Vol.10 (4), p.593-598

2008

Link zum Volltext

Verfügbarkeit prüfen

Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene

Human mutation, 2004-02, Vol.23 (2), p.111-116

2004

Link zum Volltext

Verfügbarkeit prüfen

Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT

PloS one, 2015-12, Vol.10 (12), p.e0143305-e0143305

2015

Link zum Volltext

Verfügbarkeit prüfen

EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy

Neuro-oncology (Charlottesville, Va.), 2008-12, Vol.10 (6), p.946-957

2008

Link zum Volltext

Verfügbarkeit prüfen

Impaired Pten expression in human malignant peripheral nerve sheath tumours

PloS one, 2012-11, Vol.7 (11), p.e47595

2012

Link zum Volltext

Verfügbarkeit prüfen

Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo

PloS one, 2014-10, Vol.9 (10), p.e107760-e107760

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of splicing mutations on NF2-transcripts: Transcript analysis and information theoretic predictions

Genes chromosomes & cancer, 2011-08, Vol.50 (8), p.571-584

2011

Link zum Volltext

Verfügbarkeit prüfen

Empirically downgrading 10 constitutional missense variants of the NF1 gene based on co‐existing truncating variants

American journal of medical genetics. Part A, 2021-02, Vol.185 (2), p.602-603

2021

Link zum Volltext

Verfügbarkeit prüfen

Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts

BMC research notes, 2018-07, Vol.11 (1), p.520-520, Article 520

2018

Link zum Volltext

Verfügbarkeit prüfen

Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient

PloS one, 2015-03, Vol.10 (3), p.e0119030-e0119030

2015

Link zum Volltext

Verfügbarkeit prüfen

Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity

Carcinogenesis (New York), 2006-03, Vol.27 (3), p.664-671

2006

Link zum Volltext

Verfügbarkeit prüfen

Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures

Journal of clinical neurology (Seoul, Korea), 2015-04, Vol.11 (2), p.172-177

2015

Link zum Volltext

Verfügbarkeit prüfen

Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model

Journal of neuro-oncology, 2010-05, Vol.98 (1), p.11-19

2010

Link zum Volltext

Verfügbarkeit prüfen

The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells

The American journal of pathology, 2017-07, Vol.187 (7), p.1623-1632

2017

Link zum Volltext

Verfügbarkeit prüfen

Ral Overactivation in Malignant Peripheral Nerve Sheath Tumors

Molecular and Cellular Biology, 2009-07, Vol.29 (14), p.3964-3974

2009

Link zum Volltext

Verfügbarkeit prüfen

Impairment of Procedural Learning and Motor Intracortical Inhibition in Neurofibromatosis Type 1 Patients

EBioMedicine, 2015-10, Vol.2 (10), p.1430-1437

2015

Link zum Volltext

Verfügbarkeit prüfen

Muscle action potential scans and ultrasound imaging in neurofibromatosis type 2

Muscle & nerve, 2017-03, Vol.55 (3), p.350-358

2017

Link zum Volltext

Verfügbarkeit prüfen

Intact procedural learning and motor intracortical inhibition in adult neurofibromatosis type 1 gene carriers

Clinical neurophysiology, 2021-09, Vol.132 (9), p.2037-2045

2021

Link zum Volltext

Verfügbarkeit prüfen

Constitutional NF1 mutations in neurofibromatosis 1 patients with malignant peripheral nerve sheath tumors

Human mutation, 2003-11, Vol.22 (5), p.420-420

2003

Link zum Volltext

Verfügbarkeit prüfen

Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin

Clinical cancer research, 2010-10, Vol.16 (20), p.5048-5057

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(99)

Publikationsform

Artikel
(103)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pronounced maternal parent-of-origin bias for type-1 NF1 microdeletions

The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1

Management of neurofibromatosis type 1-associated plexiform neurofibromas

Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis

Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1

Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene

Nerve Sheath Tumors in Neurofibromatosis Type 1: Assessment of Whole-Body Metabolic Tumor Burden Using F-18-FDG PET/CT

EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy

Impaired Pten expression in human malignant peripheral nerve sheath tumours

Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo

Effects of splicing mutations on NF2-transcripts: Transcript analysis and information theoretic predictions

Empirically downgrading 10 constitutional missense variants of the NF1 gene based on co‐existing truncating variants

Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts

Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient

Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity

Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy

Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures

Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model

The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells

Ral Overactivation in Malignant Peripheral Nerve Sheath Tumors

Impairment of Procedural Learning and Motor Intracortical Inhibition in Neurofibromatosis Type 1 Patients

Muscle action potential scans and ultrasound imaging in neurofibromatosis type 2

Intact procedural learning and motor intracortical inhibition in adult neurofibromatosis type 1 gene carriers

Constitutional NF1 mutations in neurofibromatosis 1 patients with malignant peripheral nerve sheath tumors

Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin

Suchergebnisse filtern